Genetic drift in hypervariable region 1 of the viral genome in persistent hepatitis C virus infection - sprookjes - yvandenbroek - TriplyDB

Genetic drift in hypervariable region 1 of the viral genome in persistent hepatitis C virus infection

Genetic drift in hypervariable region 1 of the viral genome in persistent hepatitis C virus infection

http://www.wikidata.org/entity/Q27485921

about

Hepatitis C virus core protein interacts with the cytoplasmic tail of lymphotoxin-beta receptor Hepatitis C virus molecular evolution: transmission, disease progression and antiviral therapy Identification of a domain containing B-cell epitopes in hepatitis C virus E2 glycoprotein by using mouse monoclonal antibodies.Acute hepatitis C virus structural gene sequences as predictors of persistent viremia: hypervariable region 1 as a decoy Functional role of hepatitis C virus chimeric glycoproteins in the infectivity of pseudotyped virus Long-term evolution of the hypervariable region of hepatitis C virus in a common-source-infected cohort.Evolution of hypervariable region 1 of hepatitis C virus in primary infection Hypervariable region 1 sequence stability during hepatitis C virus replication in chimpanzees.Dominant role of host selective pressure in driving hepatitis C virus evolution in perinatal infection.Evolution of the hepatitis C virus second envelope protein hypervariable region in chronically infected patients receiving alpha interferon therapy Nonrandom distribution of hepatitis C virus quasispecies in plasma and peripheral blood mononuclear cell subsets Antigenicity and immunogenicity of novel chimeric hepatitis B surface antigen particles with exposed hepatitis C virus epitopes.Production and Characterization of Monoclonal Antibodies Specific for a Conserved Epitope within Hepatitis C Virus Hypervariable Region 1 Persistent and transient replication of full-length hepatitis C virus genomes in cell culture Impact of highly active antiretroviral therapy and immunologic status on hepatitis C virus quasispecies diversity in human immunodeficiency virus/hepatitis C virus-coinfected patients.Effect of hepatitis C virus (HCV) NS5B-nucleolin interaction on HCV replication with HCV subgenomic replicon.Characterization of hepatitis C virus replication in cloned cells obtained from a human T-cell leukemia virus type 1-infected cell line, MT-2 Epitope mapping of antibodies directed against hypervariable region 1 in acute self-limiting and chronic infections due to hepatitis C virus Immunization with plasmid DNA encoding hepatitis C virus envelope E2 antigenic domains induces antibodies whose immune reactivity is linked to the injection mode Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein How Escherichia coli can bias the results of molecular cloning: preferential selection of defective genomes of hepatitis C virus during the cloning procedure Advanced molecular surveillance of hepatitis C virus Hepatitis C virus hypervariable region 1 modulates receptor interactions, conceals the CD81 binding site, and protects conserved neutralizing epitopes.A phase I clinical trial of dendritic cell immunotherapy in HCV-infected individuals Dichotomy of glycoprotein g gene in herpes simplex virus type 1 isolates Multigene tracking of quasispecies in viral persistence and clearance of hepatitis C virus.Prospects for dendritic cell vaccination in persistent infection with hepatitis C virus Sequence diversity of hepatitis C virus: implications for immune control and therapy.Phylogenetic analysis of clinical herpes simplex virus type 1 isolates identified three genetic groups and recombinant viruses Adaptive immunity to the hepatitis C virus.The past, present and future of neutralizing antibodies for hepatitis C virus.Role of hypervariable region 1 for the interplay of hepatitis C virus with entry factors and lipoproteins.Effect of interaction between hepatitis C virus NS5A and NS5B on hepatitis C virus RNA replication with the hepatitis C virus replicon.Replication of hepatitis C virus in cultured non-neoplastic human hepatocytes.Coevolution of the hepatitis C virus polyprotein sites in patients on combined pegylated interferon and ribavirin therapy.HCV E1E2-MF59 vaccine in chronic hepatitis C patients treated with PEG-IFNα2a and Ribavirin: a randomized controlled trial.Virus isolate-specific antibodies against hypervariable region 1 of the hepatitis C virus second envelope protein, gp70.Hypervariable Region 1 in Envelope Protein 2 of Hepatitis C Virus: A Linchpin in Neutralizing Antibody Evasion and Viral Entry

P2860

Q24313170-C56FF479-C38E-4A81-ABEB-562199323E41 Q26853500-CEC033E1-2366-45BF-97A1-453A7975F134 Q27469334-FC9E0D12-651D-4208-A9C1-F363DDC434B9 Q27469352-42359DF0-BE1F-4CD9-955B-8CADC5704DC4 Q27469536-F401EBF4-C381-428F-AB5B-1715FA51D53E Q27469567-FAB17BB4-D49F-4918-9D64-DD1649A72B3D Q27469585-2C0EF0C8-3586-45FD-A2F9-7CAB617BA4C1 Q27469647-EAB7A22C-8050-40B5-B5A2-18948300986D Q27469661-B4FA4780-4201-4923-BF16-25D34447D60E Q27469719-94355732-B3BC-4214-BF70-BBD48FBD9B1A Q27469739-43AA71AA-0FED-410C-A3A0-734B84A99F61 Q27469889-4BC9FBA6-0C13-481D-96B4-7F5CF58DB420 Q27470002-84A0C4AC-7CBF-4D2F-9572-8567C40C2776 Q27472869-E51E9147-5319-4CED-B272-A8DEBB9D68FF Q27473086-9A4210D8-185A-4331-A6A9-1E2844FF8456 Q27473141-1FFFDE12-4787-4B49-8306-5DD595801428 Q27480746-8F7434A8-776C-41A4-8AB5-A1CDBF4A0DA0 Q27480822-57C95371-7A85-452B-B618-4FDBC465E8FF Q27480864-559C8C05-319E-4468-9A54-B9C7DCE75DD6 Q27487933-CC3FAB84-9267-4BEF-9FF1-DF0030C033E1 Q27491290-3AAA7547-5F26-457A-B650-D273A282DE5A Q28650908-76EB6191-A317-4931-A239-FDE7808A6BC0 Q33877342-9E68A438-82A1-46D5-B469-60300D62DCFE Q34091925-AF5FABB4-DDC9-4EB6-BBC3-634990875915 Q34193783-64CC28E8-4E74-4BE4-A35F-D9835A926F01 Q35010266-6C0DD857-BA56-46C4-B600-168DD0B4FCA6 Q35784239-73A8E905-4A89-43AA-9CE9-F550ABD6A4C3 Q36179696-CBACA61B-FF81-4A0F-B198-6DD19FA9ACFE Q37511553-A4FF623D-7183-4378-B0E1-8BFCE3209EC4 Q37805839-9FF28E13-0E89-4E09-8EE7-FECE307551F1 Q38192357-3105BF00-7164-4665-B20E-19DBE2BBB950 Q38964215-584FFB49-B61E-44AE-9942-804D991025A9 Q40584601-ED59ADB9-0490-4D12-8869-1AE76F94135E Q41179886-E98537D2-6108-41C4-9095-872CC2B5E575 Q41841986-3A702FB3-2B30-4F37-8848-1D41A0AE80A2 Q42223373-14BB150E-040E-4E3E-BE98-0F8BCEDC3A4E Q43036337-8A497A7B-1141-4DC7-9A80-D3865482D552 Q57490859-3F1BBC0F-3B93-48DF-B6C4-B074C0C974DF

P2860

Genetic drift in hypervariable region 1 of the viral genome in persistent hepatitis C virus infection

http://www.wikidata.org/entity/Q27485921

description

1994 nî lūn-bûn

@nan

1994 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

1994 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

1994年の論文

@ja

1994年論文

@yue

1994年論文

@zh-hant

1994年論文

@zh-hk

1994年論文

@zh-mo

1994年論文

@zh-tw

1994年论文

@wuu

name

Genetic drift in hypervariable ...... nt hepatitis C virus infection

@ast

Genetic drift in hypervariable ...... nt hepatitis C virus infection

@en

Genetic drift in hypervariable ...... nt hepatitis C virus infection

@nl

type

label

Genetic drift in hypervariable ...... nt hepatitis C virus infection

@ast

Genetic drift in hypervariable ...... nt hepatitis C virus infection

@en

Genetic drift in hypervariable ...... nt hepatitis C virus infection

@nl

prefLabel

Genetic drift in hypervariable ...... nt hepatitis C virus infection

@ast

Genetic drift in hypervariable ...... nt hepatitis C virus infection

@en

Genetic drift in hypervariable ...... nt hepatitis C virus infection

@nl

P1433

Q27485921-E8E75F2D-3293-485A-A7F5-43E2E083332A

P1476

Q27485921-CE36DD82-8E47-42CA-BB92-9FE3E488583E

P2093

Q27485921-399FEC44-274D-4407-864B-0B66BE13B80C

Q27485921-477E8ABB-8B80-4480-9367-DB42AA09D311

Q27485921-5FC5F05E-5E68-4B06-81F0-C1946E5F35A9

Q27485921-6AAD6864-DDDD-4BE4-8ADF-B1D608BD698D

Q27485921-7299ABBA-7ECB-40B0-9DEA-154C2739F0C2

Q27485921-7C5D1719-1E74-4569-81CD-4F7EFD08D383

Q27485921-84724F1D-5F7C-4575-BE83-83B531975151

P2860

Q27485921-054533FB-F7B2-4CB5-9EEC-A114561CEF83

Q27485921-08066B63-3A51-43A9-9C09-8DFD4462F66D

Q27485921-139D9647-4425-4607-A0DF-7FB1EF5E3A2B

Q27485921-1C743E1C-6BC8-4AFD-B96D-F1B1E9D0CD7E

Q27485921-1F31216F-57B8-4D3E-9064-EE2BD627CF56

Q27485921-27DB97E7-5F9E-48A7-83AA-54250725C6D2

Q27485921-29EA8932-9834-422E-8176-3677B7B5A413

Q27485921-350C3B8F-9625-4629-9C47-C42F94E3B81B

Q27485921-41104BF7-A050-4FE5-919E-63C9E0D0426F

Q27485921-416A459E-4FF4-4B34-9EE2-9903B884D25E

P304

Q27485921-DA1A28B2-8994-4CA2-ADEA-2F39C4CA3B4C

P31

Q27485921-76FEF691-3BAC-4C91-9381-C69BA852C4E0

P433

Q27485921-54A6EE74-2420-41F8-A5C0-6B44F95C9F9B

P478

Q27485921-CA55B936-B0C4-4983-80F9-6F87305A6D9A

P577

Q27485921-B04A7840-F77B-4E30-818E-2A95B815DF53

P698

Q27485921-0E7CF843-9B68-44A7-99B6-8AC8A5968E4B

P932

Q27485921-42F27DE2-3F42-498A-9FB2-723AD21C911B

P1433

Journal of Virology

P1476

Genetic drift in hypervariable ...... nt hepatitis C virus infection

@en

P2093

Hijikata M

http://www.w3.org/2001/XMLSchema#string

Kato N

http://www.w3.org/2001/XMLSchema#string

Nakazawa T

http://www.w3.org/2001/XMLSchema#string

Ohkoshi S

http://www.w3.org/2001/XMLSchema#string

Ootsuyama Y

http://www.w3.org/2001/XMLSchema#string

Sekiya H

http://www.w3.org/2001/XMLSchema#string

Shimotohno K

http://www.w3.org/2001/XMLSchema#string

P2860

Humoral immune response to hypervariable region 1 of the putative envelope glycoprotein (gp70) of hepatitis C virus

Two distinct proteinase activities required for the processing of a putative nonstructural precursor protein of hepatitis C virus

Structure and organization of the hepatitis C virus genome isolated from human carriers

Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution

Genetic organization and diversity of the hepatitis C virus

Gene mapping of the putative structural region of the hepatitis C virus genome by in vitro processing analysis

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis

An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis

Hepatitis C virus infection is associated with the development of hepatocellular carcinoma

P304

4776-4784

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

68

http://www.w3.org/2001/XMLSchema#string

P577

1994-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

7518526

http://www.w3.org/2001/XMLSchema#string

P932

236417

http://www.w3.org/2001/XMLSchema#string